Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	92	118	147	42	15	27
Market Cap Growth	-18.32%	-19.46%	246.10%	175.83%	-43.79%	420.70%
Enterprise Value	73	107	142	39	11	22
Last Close Price	0.08	0.10	0.14	0.05	0.02	0.06
PS Ratio	28.62	34.44	75.34	29.21	52.08	27.69
PB Ratio	4.86	5.90	13.10	11.24	2.02	3.05
P/TBV Ratio	4.86	5.90	13.10	11.24	2.06	3.10
EV/Sales Ratio	22.59	31.02	72.90	26.83	37.85	22.28
Debt / Equity Ratio	-	-	-	-	0.02	0.01
Net Debt / Equity Ratio	-1.02	-1.04	-1.13	-1.37	-0.78	-0.74
Net Debt / EBITDA Ratio	2.31	2.68	1.44	0.61	0.79	1.74
Net Debt / FCF Ratio	2.80	2.84	1.81	0.81	0.94	1.79
Asset Turnover	0.20	0.20	0.21	0.20	0.03	0.11
Quick Ratio	15.09	14.06	6.32	3.08	4.05	4.28
Current Ratio	15.36	14.18	6.45	3.22	4.37	4.33
Return on Equity (ROE)	-52.05%	-47.98%	-116.55%	-178.67%	-103.87%	-76.96%
Return on Assets (ROA)	-32.25%	-28.30%	-59.16%	-73.48%	-47.72%	-28.43%
Return on Capital Employed (ROCE)	-44.80%	-39.30%	-78.90%	-227.80%	-98.60%	-44.00%
Earnings Yield	-8.63%	-6.34%	-5.95%	-23.96%	-55.95%	-18.42%
FCF Yield	-7.54%	-6.20%	-4.79%	-15.06%	-40.91%	-13.54%
Buyback Yield / Dilution	-14.71%	-16.55%	-32.32%	-29.45%	-66.10%	-132.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.